about
The histone demethylase Jarid1b ensures faithful mouse development by protecting developmental genes from aberrant H3K4me3MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinomaImmunotherapy for stage I-III non-small cell lung cancer treated with surgery or radiotherapy with curative intentMAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agentsSynaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBsMAGE-RING protein complexes comprise a family of E3 ubiquitin ligasesSperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cellsLuzp4 defines a new mRNA export pathway in cancer cellsCancer/Testis Antigen PASD1 Silences the Circadian ClockIdentification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1Upregulation of meiosis-specific genes in lymphoma cell lines following genotoxic insult and induction of mitotic catastropheAndrogen receptor molecular biology and potential targets in prostate cancerDNA methylation-dependent regulation of BORIS/CTCFL expression in ovarian cancerFocus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human gliomaGene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigenExpression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigenEpidermal-growth-factor-dependent phosphorylation and ubiquitinylation of MAGE-11 regulates its interaction with the androgen receptorHypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumorsSperm protein 17 is expressed in human nervous system tumours.Expression of evolutionarily novel genes in tumorsMechanisms of immune evasion and current status of checkpoint inhibitors in non-small cell lung cancerDoes it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic InstabilityProstate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancerTargeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challengesGenome management and mismanagement--cell-level opportunities and challenges of whole-genome duplicationRegulation of blood-testis barrier by actin binding proteins and protein kinasesThe potential for immunogenicity of autologous induced pluripotent stem cell-derived therapiesCancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerGenetic engineering with T cell receptorsDnmt3b Prefers Germ Line Genes and Centromeric Regions: Lessons from the ICF Syndrome and Cancer and Implications for DiseasesTrial watch: Dendritic cell-based anticancer therapyNew genes contribute to genetic and phenotypic novelties in human evolutionIn vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells.Stem cells, senescence, neosis and self-renewal in cancer.Lamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biologyT-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesTumor neoantigens: building a framework for personalized cancer immunotherapyImmunotherapy for Bone and Soft Tissue Sarcomas
P2860
Q21092410-A6EAF870-3346-4671-A705-7C0E21803479Q21134039-D02D3D6A-EE2A-4145-91F6-89460344D403Q24194081-8BA916C3-6EBE-42E3-9EDF-28BC1FD5007EQ24297439-82254DB3-CA19-4DDD-A68E-F4E7EA6D5ABFQ24298264-F8DA3E94-EFB6-4BA2-A29F-AFD112AA158AQ24298306-14A6BCCC-F19C-4D40-8255-89223F894683Q24300816-8235A3CD-4936-41FB-B491-2CA1D8840752Q24303925-198D3240-5089-4174-BB14-6E80BA78221BQ24318387-D8031B5E-ED0B-4DCF-97B7-3588BC9FDA8FQ24337215-97419440-1603-4B30-B945-F55750418294Q24338624-F2B08A21-5BF8-4F1F-B259-C844842E191FQ24539125-E80CE1BA-CA9E-40C0-A13D-9BF0EEF74A50Q24602861-6B44C779-57A8-4860-8F14-38B9E93FFB11Q24615113-4F43E6A6-2DAA-4BB0-806C-91A7E355EE18Q24615166-330E9C0D-AD68-43DA-B2EE-BCCD82820DEDQ24623215-141F97DE-812E-4AFC-A5CD-60E696DE8298Q24652084-8CE52B9A-3561-403C-B4F7-0930CFAD8083Q24652929-1DC5BAF5-673E-4CD1-8932-42DB0FA3607FQ24678285-8E156779-F588-43DC-A945-38FFC12E7875Q25256674-9AB1F655-D4FC-4B33-A9F1-7DA8D71C01D3Q26738894-F676EE31-3FDA-4B6A-AFA4-8B1853DD0A15Q26740288-892B6610-639C-47F0-9623-F8DE04213E3AQ26741977-8F37F5E3-B031-4D4E-9629-F2A108395446Q26747510-1955D9B2-75C1-400E-9D74-9D667B13EBABQ26748530-427E34E7-7584-4CB8-8F01-56AA0B6A4F33Q26774074-15287222-15FA-411A-8F1D-FF1F3C8D2F7AQ26774293-92541C4B-532D-4C1F-87DE-D5D10445B2F4Q26775517-4487FBC2-2558-4A5D-BA11-9FA79C2315B9Q26851666-842DA8BA-92C2-4C94-BD8C-80CB3DFCD749Q26852766-3F8025B6-0F0B-4E11-BCA0-BAAB4F44E5E4Q26995677-0420735D-8DC5-4252-8E57-F2380FCE8166Q27009992-40E24B6E-BB2A-47A4-9A97-3632D254438CQ27024047-3C2E6F24-54F2-4EA4-BCEB-B3B5F64F4198Q27026809-D54ECE40-F85D-40C4-91A1-34154FB4B8B6Q27329469-83FF32EA-3339-4D3B-8506-B520DA351B1DQ27497212-58D667E6-BD95-4C1B-8048-21F036DA7B26Q27687804-4C61C516-1909-42B4-ABA1-4AA6A1B3EAFFQ28074619-60358D4D-2DB6-4F68-A5F1-37A631EE972DQ28082704-1BA82441-1BE4-409C-B155-B3673641FA9FQ28088363-92EFAA61-FFCC-4103-BE56-C3462B54503B
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cancer/testis antigens, gametogenesis and cancer
@ast
Cancer/testis antigens, gametogenesis and cancer
@en
type
label
Cancer/testis antigens, gametogenesis and cancer
@ast
Cancer/testis antigens, gametogenesis and cancer
@en
prefLabel
Cancer/testis antigens, gametogenesis and cancer
@ast
Cancer/testis antigens, gametogenesis and cancer
@en
P2093
P2860
P3181
P356
P1476
Cancer/testis antigens, gametogenesis and cancer
@en
P2093
P2860
P2888
P304
P3181
P356
10.1038/NRC1669
P407
P577
2005-08-01T00:00:00Z
P6179
1019623495